These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6147938)

  • 21. Metabolic studies in patients with nadolol: oral and intravenous administration.
    Dreyfuss J; Brannick LJ; Vukovich RA; Shaw JM; Willard DA
    J Clin Pharmacol; 1977; 17(5-6):300-7. PubMed ID: 16040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of intravenous and oral betaxolol on antegrade and retrograde conduction in patients with atrioventricular nodal reentrant and atrioventricular reentrant tachycardia.
    Kühlkamp V; Ickrath O; Haasis R; Seipel L
    Eur Heart J; 1989 Jun; 10(6):493-501. PubMed ID: 2569398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacokinetics and metabolism of bevantolol.
    Latts JR
    Angiology; 1986 Mar; 37(3 Pt 2):221-5. PubMed ID: 2871781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of flestolol in man: preliminary data.
    Achari R; Hulse JD; Drissel D; Matier WL
    Br J Clin Pharmacol; 1985 Dec; 20(6):691-4. PubMed ID: 2868745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
    Vinceneux P; Canal M; Domart Y; Roux A; Cascio B; Orofiamma B; Larribaud J; Flouvat B; Carbon C
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of topical timolol vs betaxolol on cardiopulmonary exercise performance in healthy volunteers.
    Dickstein K; Hapnes R; Aarsland T; Kristianson K; Viksmoen L
    Acta Ophthalmol (Copenh); 1988 Aug; 66(4):463-6. PubMed ID: 2904203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia.
    Saunders J; Gomeni R; Kilborn JR; Morselli PL; Sönksen PH
    Eur J Clin Pharmacol; 1981; 21(3):177-84. PubMed ID: 6119203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of betaxolol on heart rate at rest and during exercise.
    Kesteloot H; Missotten A; Coupez-Lopinot R; Sluyts R
    Acta Cardiol; 1982; 37(2):117-27. PubMed ID: 6125074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of pamatolol, a cardioselective beta adrenoreceptor blocker.
    Carruthers SG; Pentikainen P; Hosler JP; Azarnoff DL
    Clin Pharmacol Ther; 1979 Dec; 26(6):682-5. PubMed ID: 40725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New topical beta-blockers for glaucoma.
    Drug Ther Bull; 1987 Aug; 25(16):63-4. PubMed ID: 2887414
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacology and clinical pharmacokinetics of nadolol].
    Lazowski J; Wegrzyn B; Lypka A
    Pol Tyg Lek; 1981 Sep; 36(39):1521-4. PubMed ID: 6121320
    [No Abstract]   [Full Text] [Related]  

  • 32. [Timolol, betaxolol and befunolol in the treatment of glaucoma. Study of their bronchopulmonary effects].
    Pecori-Giraldi J; Collini S; Planner-Terzaghi A; Arrico L; Grechi G
    Fortschr Ophthalmol; 1988; 85(3):235-8. PubMed ID: 2905321
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of 3 topically administered beta blockers on the rabbit crystalline lens].
    Eckerskorn U; Wegener A; Hockwin O; Fournes C; Ermisch S; Müller P; Möller B
    Fortschr Ophthalmol; 1988; 85(2):139-43. PubMed ID: 2899043
    [No Abstract]   [Full Text] [Related]  

  • 34. Electrical stimulation releases 3H-betaxolol from rat atrial slices: possible role of noradrenergic nerves.
    Petruzzo P; Arbilla S; Allen J; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):253-7. PubMed ID: 2872597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term beta adrenergic antagonists in spastic bronchopathies].
    Blaive B; Nahon F; Lemoigne F; Lewest G
    Allerg Immunol (Paris); 1988 Apr; 20(4):161-2, 164-5. PubMed ID: 2900013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacology, pharmacodynamics and interactions with esmolol.
    Lowenthal DT; Porter RS; Saris SD; Bies CM; Slegowski MB; Staudacher A
    Am J Cardiol; 1985 Oct; 56(11):14F-18F. PubMed ID: 2864843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Additive effect of betaxolol and epinephrine in primary open angle glaucoma.
    Allen RC; Epstein DL
    Arch Ophthalmol; 1986 Aug; 104(8):1178-84. PubMed ID: 2874783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Corneal sensitivity after single doses of timolol, betaxolol or placebo in persons with healthy eyes--a randomized, prospective double-blind study].
    Höh H
    Fortschr Ophthalmol; 1988; 85(2):132-8. PubMed ID: 2899042
    [No Abstract]   [Full Text] [Related]  

  • 39. Determination of betaxolol, a new beta-blocker, by gas chromatography mass spectrometry: application to pharmacokinetic studies.
    Hermann P; Fraisse J; Allen J; Morselli PL; Thenot JP
    Biomed Mass Spectrom; 1984 Jan; 11(1):29-34. PubMed ID: 6142735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
    Yamada Y; Takayanagi R; Tsuchiya K; Ito K; Ohtani H; Sawada Y; Iga T
    J Ocul Pharmacol Ther; 2001 Jun; 17(3):235-48. PubMed ID: 11436944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.